Roshan Dealmark Private Limited has announced the disposal of 44,000 equity shares in Sattva Sukun Lifecare Ltd through an on-market transaction executed on March 10, 2026. The disclosure was made in compliance with SEBI regulations governing substantial acquisition and insider trading norms.

Transaction Details

The share disposal was conducted through on-market trading, with Roshan Dealmark Private Limited acting as the disposer. The company, identified by CIN U52390WB2011PTC164255 and registered at 26/1, Strand Road, Kolkata, West Bengal, belongs to the promoter and promoter group category of Sattva Sukun Lifecare Ltd.

Shareholding Pattern Changes

The transaction resulted in a marginal reduction in Roshan Dealmark's stake in the target company. Before the disposal, the promoter group held a total of 2,45,73,777 shares, representing 6.41% of the total voting capital.

Promoter Group Composition

The promoter group consists of Roshan Dealmark Private Limited and Puja Agarwal, who is identified as a Person Acting in Concert (PAC). Following the transaction, Roshan Dealmark Private Limited holds 2,44,49,777 shares, while Puja Agarwal maintains her holding of 80,000 shares.

Company Information

Sattva Sukun Lifecare Ltd is listed on the Bombay Stock Exchange with a paid-up capital of ₹38,36,01,248, comprising 383,601,248 shares of ₹1 each. The target company is headquartered at 101, 1st Floor Crystal Rose CHS LTD, Datta Mandir Road, Mahavir Nagar, Kandivali West, Mumbai-400067.

Regulatory Compliance

The disclosure was filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015. The document was signed by Mit Tarunkumar Brahmbhatt, Director of Roshan Dealmark Private Limited, bearing DIN 06520600.

Sattva Sukun Lifecare Limited (formerly Mayukh Dealtrade Limited) has informed BSE Limited that its board meeting scheduled for February 14, 2026, could not be conducted due to the absence of requisite quorum. The meeting was convened to consider and approve unaudited financial results for the quarter ended December 31, 2025.

Meeting Postponement Details

The company has submitted a clarification to BSE Limited under Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, explaining the delay in filing Q3FY26 financial results. As the required quorum was not present, the meeting stood adjourned in accordance with the provisions of the Companies Act, 2013.

Impact on Financial Results

Consequently, the approval and submission of the unaudited financial results have been delayed. The company has assured that the adjourned board meeting will be convened on Monday, February 16, 2026, and the unaudited financial results shall be considered and submitted to the exchange immediately thereafter within the prescribed time.

Original Meeting Agenda

Regulatory Compliance

The company remains committed to statutory compliance and timely disclosures in accordance with SEBI regulations. Company Secretary Poonam Rani has digitally signed the official communication to BSE Limited, requesting the exchange to take the explanation on record.

Company Information

The trading window restrictions that were implemented from January 01, 2026, for designated persons and their immediate relatives under SEBI insider trading regulations remain in effect until 48 hours after the conclusion of the rescheduled board meeting.